‘This is an extremely welcome result.’

New findings about the use of a steroid in treating COVID-19 constitute an “important step” in its management, says one pharmacy expert Researchers from the University of Oxford have released the results of a trial into the low-cost steroid dexamethasone as a treatment for COVID-19, saying that it reduced deaths by one-third in ventilated patients

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Real talk on pain
Next Big change for Pharmacy of the Year